Open AccessCombination treatment with nivolumab and Rigvir of a progressive stage IIC skin melanoma patient
Author(s) -
Brokāne Linda,
Jaunalksne Inta,
Tilgase Andra,
Olmane Evija,
Petroška Donatas,
Rasa Agnija,
Alberts Pēteris
Publication year - 2019
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.2182
Subject(s) - medicine , nivolumab , melanoma , stage (stratigraphy) , radiation therapy , surgery , dermatology , metastatic melanoma , cancer , immunotherapy , cancer research , paleontology , biology
A 35‐year‐old male patient was diagnosed with stage IIC skin melanoma that rapidly progressed after surgery. Treatment was continued with radiotherapy, which did not stop further spread of disease and the patient was put on a combination of nivolumab and Rigvir. Subsequently, the progression has slowed.